COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 2821: Articles 28201-28210  | Next

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Michelena, X., Borrell, H., Lopez-Corbeto, M., Lopez-Lasanta, M., Moreno, E., Pascual-Pastor, M., Erra, A., Serrat, M., Espartal, E., Anton, S., Anez, G. A., Caparros-Ruiz, R., Pluma, A., Trallero-Araguas, E., Barcelo-Bru, M., Almirall, M., De Agustin, J. J., Llados, J., Julia, A., Marsal, S.
10.1101/2020.04.30.20086090 — Posted: 2020-05-05
TRACKING AND PREDICTING COVID-19 RADIOLOGICAL TRAJECTORY USING DEEP LEARNING ON CHEST X-RAYS: INITIAL ACCURACY TESTING
Duchesne, S., Gourdeau, D., Archambault, P., Chartrand-Lefebvre, C., Dieumegarde, L., Forghani, R., Gagne, C., Hains, A., Hornstein, D., Le, H., Lemieux, S., Levesque, M.-H., Martin, D., Rosenbloom, L., Tang, A., Vecchio, F., Duchesne, N.
10.1101/2020.05.01.20086207 — Posted: 2020-05-05 Discussion: Offsite
Does weather affect the growth rate of COVID-19, a study to comprehend transmission dynamics on human health
Sil, A.
10.1101/2020.04.29.20085795 — Posted: 2020-05-05
Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France
Hoertel, N., Blachier, M., Blanco, C., Olfson, M., Massetti, M., Sanchez Rico, M., Limosin, F., Leleu, H.
10.1101/2020.04.30.20086264 — Posted: 2020-05-05 Discussion: Onsite | Offsite
The impact of believing you have had COVID-19 on behaviour: Cross-sectional survey
Smith, L. E., Mottershaw, A. L., Egan, M., Waller, J., Marteau, T. M., Rubin, G. J.
10.1101/2020.04.30.20086223 — Posted: 2020-05-05
Hindsight is 2020 vision: Characterisation of the global response to the COVID-19 pandemic
Warne, D. J., Ebert, A., Drovandi, C., Mira, A., Mengersen, K.
10.1101/2020.04.30.20085662 — Posted: 2020-05-05
Beyond predicting the number of infections: predicting who is likely to be COVID negative or positive
Zhang, S. X., Sun, S., Jahanshahi, A. A., Wang, Y., Madavani, A. N., Dinani, M. M.
10.1101/2020.04.30.20086348 — Posted: 2020-05-05
Mathematical Model with Social Distancing Parameter for Early Estimation of COVID-19 Spread
Chandra, S. K., Singh, A., Bajpai, M. K.
10.1101/2020.04.30.20086611 — Posted: 2020-05-05
Elevated D-Dimer Levels are Associated with Increased Risk of Mortality in COVID-19: A Systematic Review and Meta-Analysis
Shah, S., Shah, K., Patel, S. B., Patel, F. S., Osman, M., Velagapudi, P., Turagam, M. K., Lakkireddy, D., Garg, J.
10.1101/2020.04.29.20085407 — Posted: 2020-05-05
A clinical and biological framework on the role of visceral fat tissue and leptin in SARS-CoV-2 infection related respiratory failure
van der Voort, P., Moser, J., Zandstra, D. F., Muller Kobold, A. C., Knoester, M., Calkhoven, C. F., Hamming, I., van Meurs, M.
10.1101/2020.04.30.20086108 — Posted: 2020-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).